search
› › › FDA approves first RSV drug to be broadly available for babies, toddlers
FDA approves first RSV drug to be broadly available for babies, toddlers

FDA approves first RSV drug to be broadly available for babies, toddlers

By Monday, July 17, 2023 Comment Edit

The monoclonal antibody, called Beyfortus, is the first of its kind likely to be available beyond a small population of immunocompromised children.

     


from USATODAY - News Top Stories https://ift.tt/Nhi7xgz
via IFTTT

0 Response to "FDA approves first RSV drug to be broadly available for babies, toddlers"

Post a Comment

Subscribe to: Post Comments (Atom)